| Schedule of Segment Information |
The following table is a summary
of segment information for three months ended March 31, 2021 and 2020 (amounts in thousands):
| |
|
For the three months ended |
|
| |
|
March 31, 2021 |
|
|
March 31, 2020 |
|
| Net revenues |
|
|
|
|
|
|
|
|
| Diagnostic services |
|
$ |
12,737 |
|
|
$ |
- |
|
| Consumer products |
|
|
2,534 |
|
|
|
1,888 |
|
| Consolidated net revenue |
|
|
15,271 |
|
|
|
1,888 |
|
| Cost of revenue |
|
|
|
|
|
|
|
|
| Diagnostic services |
|
|
4,345 |
|
|
|
- |
|
| Consumer products |
|
|
1,999 |
|
|
|
1,473 |
|
| Consolidated cost of revenue |
|
|
6,344 |
|
|
|
1,473 |
|
| Depreciation and amortization expense |
|
|
|
|
|
|
|
|
| Diagnostic services |
|
|
345 |
|
|
|
- |
|
| Consumer products |
|
|
3 |
|
|
|
5 |
|
| Total Depreciation and amortization expense |
|
|
348 |
|
|
|
5 |
|
| Operating and other expenses |
|
|
7,522 |
|
|
|
1,219 |
|
| Income (loss) from continuing operations, before income taxes |
|
|
|
|
|
|
|
|
| Diagnostic services |
|
|
2,839 |
|
|
|
- |
|
| Consumer products |
|
|
(35 |
) |
|
|
410 |
|
| Unallocated corporate |
|
|
(1,748 |
) |
|
|
(1,219 |
) |
| Total income (loss) from continuing operations, before income taxes |
|
|
1,057 |
|
|
|
(809 |
) |
| Net income (loss) |
|
$ |
1,057 |
|
|
$ |
(809 |
) |
The following table is a summary
of segment information for three months ended March 31, 2021 and 2020 (amounts in thousands):
| |
|
March 31 |
|
|
December 31, |
|
| |
|
2021 |
|
|
2020 |
|
| |
|
|
|
|
|
|
| ASSETS |
|
|
|
|
|
|
|
|
| Diagnostic services |
|
$ |
40,349 |
|
|
$ |
13,410 |
|
| Consumer products |
|
|
5,589 |
|
|
|
6,261 |
|
| Unallocated corporate |
|
|
39,506 |
|
|
|
11,734 |
|
| Total assets |
|
$ |
85,444 |
|
|
$ |
31,405 |
|
|